Position in GILD
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$351,604
-$51,175 QoQ
Shares Held
2,783
-3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,567
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DeDora Capital, Inc. holds $14,607,227 across 7 Drug Manufacturers - General names. GILD ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,644 | $4,370,723 | |
| 2 | ABBV |
AbbVie Inc.
|
15,149 | $3,812,094 | |
| 3 | AMGN |
Amgen Inc
|
7,475 | $2,706,847 | |
| 4 | JNJ |
Johnson & Johnson
|
6,554 | $1,664,519 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,956 | $1,279,346 | |
| 6 | AZN |
Astrazeneca PLC
|
2,226 | $422,094 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,783 | $351,604 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $351,604 | 2,783 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $402,779 | 2,890 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $354,718 | 2,890 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $334,221 | 3,011 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $333,829 | 3,011 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $337,270 | 3,010 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $293,644 | 3,179 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $269,377 | 3,213 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $481,299 | 7,015 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $525,275 | 7,171 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $824,114 | 10,173 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $757,943 | 10,114 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $689,314 | 8,944 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $721,258 | 8,693 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $744,319 | 8,670 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $502,711 | 8,149 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $517,596 | 8,374 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,025,334 | 17,247 | Shares | Sole | 2022-04-14 | |
| 2021-09-30 | $1,050,823 | 15,044 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $1,012,173 | 14,699 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $954,649 | 14,771 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $852,868 | 14,639 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $969,713 | 15,346 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,036,074 | 13,466 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $942,499 | 12,607 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||